Non small cell lung cancer pathophysiology
|
Non Small Cell Lung Cancer Microchapters |
|
Differentiating Non Small Cell Lung Cancer from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Non small cell lung cancer pathophysiology On the Web |
|
American Roentgen Ray Society Images of Non small cell lung cancer pathophysiology |
|
Directions to Hospitals Treating Non small cell carcinoma of the lung |
|
Risk calculators and risk factors for Non small cell lung cancer pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
Non-small cell lung cancer arises from the epithelial cells of the bronchioles and alveoli, which are normally involved in the protection of the airways. Non-small cell lung cancer is an invasive and rapidly growing cancer which may metastasize to different organs of the body. Genes involved in the pathogenesis of non-small cell lung cancer include EGFR, KRAS, HER2, BRAF, and ALK. Findings on gross pathology depends on the histological subtypes of non-small cell lung cancer. On microscopic histopathological analysis non-small cell lung cancer usually demonstrates large cells with abundant cytoplasm and no stippled chromatin.
Pathogenesis
The pathogenesis of non-small cell lung cancer depends on the type of histological subtype of lung cancer.[1]
- Non-small cell lung cancer arises from the epithelial cells of the bronchioles and alveoli, which are normally involved in the protection of the airways.
- The genetic pathogenesis of non-small cell lung cancer is due to the amplification of oncogenes and inactivation of tumor suppressor genes.
- Non-small cell lung cancer is an invasive and rapidly growing cancer which may metastasize to different organs of the body.
Pathogenesis according to histopathological subtypes:
- Adenocarcinoma of the lung:
- Adenocarcinoma arises from the bronchial mucosal glands of the lung (main, lobar, or segmental bronchi, or lung parenchyma), which are normally involved in eliminating microbes and avoiding microbial growth in the epithelial cells of the lung.
- Lung adenocarcinoma usually occurs in a peripheral location within the lung.
- In the majority of the patients, cancer arises from precursor lesions, such as pre-existing scars or inflammation (chronic infections).
- Lung adenocarcinoma can also result from multiple genetic mutations.
- For more information about adenocarcinoma of the lung pathogenesis, click here.
- Squamous cell carcinoma of the lung:
- Squamous cell carcinoma of the lung arises from bronchial epithelial cell damage, commonly caused by smoking.
- Squamous cell carcinoma usually occurs in a central location within the lung.
- For more information about squamous cell carcinoma of the lung pathogenesis, click here.
- Large cell carcinoma of the lung:
- Large cell carcinoma of the lung arises from large polygonal and anaplastic cells
- It is difficult to differentiate large cell carcinoma from other types of non small cell lung cancer.
- Large cell carcinoma of the lung usually occurs in a peripheral location within the lung.
- For more information about large cell carcinoma of the lung pathogenesis, click here.
Genetics
Development of non-small cell lung cancer is the result of multiple genetic mutations. Genetic mutations also play an important role in the treatment selection for non small cell lung cancer.[2]
- The table below describes the genes involved in the pathogenesis of non small cell lung cancer.
| Genes | Presence in non small cell-lung cancers |
|---|---|
| EGFR |
|
| KRAS |
|
| ALK |
|
| HER2 |
|
| BRAF |
|
| ROS-1 |
|
Associated Conditions
- Other conditions associated with non-small cell lung cancer, include:
- Genetic conditions
- Li–Fraumeni syndrome[3]
- Infections
Gross Pathology
- On gross pathology, findings will depend on the histological subtype of non-small cell lung cancer.
- Lung adenocarcinoma gross pathology findings, include:[6]
- Spherical tumor with well-defined borders
- Homogeneous gray-white cut surface
- Involvement of the thoracic wall
- Usually found in the peripheral lung
- Large cell lung cancer gross pathology findings, include:[6]
- Well-defined borders
- Resemblance to gross findings in adenocarcinoma
- No signs of anthracosis
- Involvement of the thoracic wall
- Squamous cell lung cancer gross pathology findings, include:[6]
- Lung mass
- Usually centrally located
- Associated with a large airway
- Usually have a central cavitation
Microscopic Pathology
On microscopic pathology, findings will depend on the histological type of non-small cell lung cancer.[6]
- Lung adenocarcinoma microscopic pathology findings, include:
- Nuclear atypia
- Eccentrically placed nuclei
- Abundant cytoplasm with mucin vacuoles
- Often conspicuous nucleoli
- Lack of intercellular bridges.
- Different patterns, include: acinar, lepidic, micropapillary, papillary, and solid.
- Large cell lung cancer microscopic pathology findings, include:
- Large polygonal cells and anaplastic cells
- No squamous or glandular differentiation
- Moderately abundant cytoplasm
- Vesicular nuclei, prominent nucleoli
- Squamous cell lung cancer microscopic pathology findings include:
- Central nucleus
- Dense appearing cytoplasm, usually eosinophilic
- Small nucleolus
- Intracellular bridges (classic feature)
On immunohistochemistry, the findings depend on the histological type of non-small cell lung cancer.[2][6]
- Common immunohistochemistry markers used for non-small cell carcinoma subtyping, include:
- TTF-1 for adenocarcinoma
- p63 and high-molecular-weight keratins for squamous cell carcinoma
- Lack of staining with neuroendocrine markers (chromogranin A, synaptophysin, and CD56)
References
- ↑ Miller YE (2005). "Pathogenesis of lung cancer: 100 year report". Am. J. Respir. Cell Mol. Biol. 33 (3): 216–23. doi:10.1165/rcmb.2005-0158OE. PMC 2715312. PMID 16107574.
- ↑ 2.0 2.1 Capelozzi VL (2009). "Role of immunohistochemistry in the diagnosis of lung cancer". J Bras Pneumol. 35 (4): 375–82. PMID 19466276.
- ↑ Caron, Olivier; Frebourg, Thierry; Benusiglio, Patrick R.; Foulon, Stéphanie; Brugières, Laurence (2017). "Lung Adenocarcinoma as Part of the Li-Fraumeni Syndrome Spectrum". JAMA Oncology. 3 (12): 1736. doi:10.1001/jamaoncol.2017.1358. ISSN 2374-2437.
- ↑ Liang H, Pan Z, Cai X, Wang W, Guo C, He J, Chen Y, Liu Z, Wang B, He J, Liang W (June 2018). "The association between human papillomavirus presence and epidermal growth factor receptor mutations in Asian patients with non-small cell lung cancer". Transl Lung Cancer Res. 7 (3): 397–403. doi:10.21037/tlcr.2018.03.16. PMC 6037964. PMID 30050777.
- ↑ Skowroński M, Iwanik K, Halicka A, Barinow-Wojewódzki A (2015). "Squamous cell lung cancer in a male with pulmonary tuberculosis". Pneumonol Alergol Pol. 83 (4): 298–302. doi:10.5603/PiAP.2015.0049. PMID 26166791.
- ↑ 6.0 6.1 6.2 6.3 6.4 Non small cell lung cancer. Libre Pathology. http://librepathology.org/wiki/Non-small_cell_lung_carcinoma Accessed on February 22, 2016